DUBLIN, Feb. 15, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/hwgmxm/global) has announced the addition of the "Global Myelodysplastic Syndrome Market 2015-2019" report to their offering.
The global myelodysplastic syndrome market to grow at a CAGR of 9.93% during the period 2015-2019.
Global Myelodysplastic Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The report covers the present scenario and the growth prospects of the global myelodysplastic syndrome market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of various drugs used for treating myelodysplastic syndrome.
Government organizations and pharmaceutical companies are conducting awareness programs to spread knowledge about the disease and associated drugs. In addition, they are also providing patient assistance programs to give low-income people with myelodysplastic syndrome access to these drugs. These two factors will surge the number of people availing treatment services, increasing the sales and consumption of drugs.
According to the report, the immune system of an individual deteriorates as aging progresses. For this reason, people aged 60 and above are more susceptible to this disease. A surge in the population of this age group will increase the need for treatment drugs, positively influencing the latter's sales and revenue.
Further, the report states that the high cost of drugs used for treating myelodysplastic syndrome can deter people from consuming them.
Key vendors
Other prominent vendors
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Product profile
Part 04: Market research methodology
Part 05: Introduction
Part 06: Disease overview
Part 07: Pipeline portfolio
Part 08: Market landscape
Part 09: Market segmentation by drug class
Part 10: Market segmentation by route of administration
Part 11: Geographical Segmentation
Part 12: Market drivers
Part 13: Impact of drivers
Part 14: Market challenges
Part 15: Impact of drivers and challenges
Part 16: Market trends
Part 17: Vendor landscape
PART 18: Key vendor analysis
PART 19: Appendix
For more information visit http://www.researchandmarkets.com/research/hwgmxm/global
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article